Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › SGMT
SUPERSTRING CAPITAL MANAGEMENT LP position in SGMT
SAGIMET BIOSCIENCES INC · Health Care
SUPERSTRING CAPITAL MANAGEMENT LP reported holding 423,006 shares of SGMT (SAGIMET BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 2.09% of its reported portfolio and ranking #19 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How SUPERSTRING CAPITAL MANAGEMENT LP's SGMT position evolved
SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in SGMT in Q3 2026 at 423,006 shares (US$4.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 423.01K | $4.18M | New |
About SGMT and 13F data
SGMT (SAGIMET BIOSCIENCES INC) is a Health Care company. 61 other funds we track also report a position in SGMT — the largest reported positions include SILVERARC CAPITAL MANAGEMENT, LLC (US$37.0M), Affinity Asset Advisors, LLC (US$25.0M), Saturn V Capital Management LP (US$19.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SGMT
- SILVERARC CAPITAL MANAGEMENT, LLC 3.75M sh · $37.01M · Q3 2026
- Affinity Asset Advisors, LLC 2.53M sh · $24.97M · Q3 2026
- Saturn V Capital Management LP 2.00M sh · $19.79M · Q3 2026
- BVF INC/IL 2.50M sh · $19.32M · Q2 2026
- Caligan Partners LP 2.50M sh · $19.32M · Q2 2026
- GREAT POINT PARTNERS LLC 2.03M sh · $15.69M · Q2 2026
- Spruce Street Capital LP 1.40M sh · $13.83M · Q3 2026
- Atom Investors LP 725.92K sh · $7.17M · Q3 2026
- Hillhouse Capital (HHLR Advisors) 724.80K sh · $5.60M · Q2 2026
- Jones Hill Capital LP 502.59K sh · $4.97M · Q3 2026
- Seven Fleet Capital Management LP 403.55K sh · $3.12M · Q2 2026
- Palo Alto Investors LP 250.00K sh · $1.93M · Q2 2026
More on SUPERSTRING CAPITAL MANAGEMENT LP
FAQ
How long has SUPERSTRING CAPITAL MANAGEMENT LP held SGMT?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed SGMT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in SGMT?
As of Q3 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 423.01K shares of SGMT (SAGIMET BIOSCIENCES INC), valued at $4.18M, representing 2.09% of its reported portfolio and ranking #19.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling SGMT?
In the latest 13F filing (Q3 2026), SUPERSTRING CAPITAL MANAGEMENT LP newly opened its position in SGMT.
Which other funds hold SGMT?
Other major institutional holders of SGMT include SILVERARC CAPITAL MANAGEMENT, LLC, Affinity Asset Advisors, LLC, Saturn V Capital Management LP, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.